XRP retests 2026 low after 11.43% weekly decline

XRP fell 11.43% over the past week to $0.9871 on Nov. 14, returning to levels last seen at its previous 2026 low. The cryptocurrency was down 4.09% over the previous 24 hours. Bitcoin fell 2.5% during the same period, while the broader cryptocurrency market declined about 2.3%.

XRP reached $0.9800 during the week, below its previous 2026 low of $0.9862. The weekly candle had not closed by Nov. 14, leaving the level unconfirmed on a weekly basis.

Selling affected both spot and derivatives markets. XRP liquidations totaled $13.95 million over 24 hours, including $12.78 million in liquidated long positions, or 92% of the total. Open interest rose 0.76% to $2.19 billion while the price declined.

The funding rate fell to negative 0.0067%, equivalent to about negative 7.3% on an annualized basis. Futures taker selling exceeded buying by 10.6%, producing a buy-to-sell ratio of 0.90. Spot-market net outflows reached $50.87 million, while trading volume fell 13.36%. U.S. spot XRP exchange-traded funds recorded $1.09 million in net redemptions on Nov. 13.

XRP traded below its 200-week moving average at $1.2861 and its 50-week moving average at $1.4101. If it closes below $0.9862 on a weekly basis, the next listed support is $0.7813. The $0.75-$0.64 area acted as resistance before XRP’s late-2024 breakout and is another potential support zone. A decline to that range would represent a drop of about 24% to 35% from $0.9871. Another historical support level is $0.4860.

Near-term liquidation levels were concentrated around $0.9760 for long positions and $1.006 for short positions. A recovery above $1.1719 would bring the weekly moving averages back into focus. Higher resistance levels were located between $1.50 and $1.69, followed by resistance at $1.8706 and $1.9531.

A weekly close above $1.1719 would put the $1.50-$1.69 range back in focus. If weekly support holds, XRP could continue trading near $1. A close below $0.9862 would put $0.7813 and the $0.64-$0.75 range in focus.

Reviewed and fact-checked by Alex Panasenko on November 14.